Monthly Archives: February 2015

WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA

SHANGHAI, February 28, 2015 /PRNewswire/ — WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading open-access R&D capability and technology platform company serving the pharmaceutical, biotechnology, and medical device industries with…

Continued growth and market share gains underline resilience of DKSH’s business model in a challenging market environment

HONG KONG, Feb. 27, 2015 /PRNewswire/ — Net sales grow by 7.1% to CHF 10.2 billion at constant exchange rates resulting in market share gains in core markets Despite the…

New BNC105 Biomarker Data to be Presented at US Cancer Conference

– 89% of biomarker positive group progression free at 6 months – Extends previous biomarker results from Phase II renal cancer trial ADELAIDE, Australia, February 27, 2015 /PRNewswire/ — Bionomics…

Syrian Mazen Darwish named IPI World Press Freedom Hero

Lawyer, human rights defender detained since 2012 VIENNA, Feb 26, 2015 – The International Press Institute (IPI) today named as its 67thWorld Press Freedom Hero prominent Syrian lawyer and human…

RM Group Enters into the PRC Market

HONG KONG, Feb. 27, 2015 /PRNewswire/ — RM Group Holdings Limited ("RM Group" or the "Company") (HKEx stock code: 8185) and its subsidiaries (the "Group") announced that it entered into a distribution…

Omnicell, Inc. Signs Agreement to Acquire Germany-based Pharmacy Automation Provider, MACH4 Pharma Systems

— Addition of Robotic Pharmacy Automation Solutions for Hospital and Retail Pharmacies to Expand Omnicell International Growth MOUNTAIN VIEW, Calif., Feb. 27, 2015 /PRNewswire/ — Omnicell, Inc. (OMCL), a leading…

TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements

CHENGDU, China, Feb. 26, 2015 /PRNewswire/ — Tianyin Pharmaceutical Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and…

Embrace the Future of Medical Technologies with Frost & Sullivan

– Medical Technologies 2015: A Frost & Sullivan Executive MindXchange will help you navigate the new healthcare landscape MOUNTAIN VIEW, Calif., Feb. 27, 2015 /PRNewswire/ — The healthcare landscape is…

China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2015

3Q15 Added 17,622 New Subscribers 3Q15 Revenue Up 10.7% YOY to RMB166.7 Million ($26.9 Million) 3Q15 Operating Income Increased to RMB67.8 Million ($10.9 Million) Conference Call to be Held February…